Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence. It plays a crucial role in gene expression regulation and can influence developmental outcomes and disease susceptibility. This study aims to elucidate the role of specific epigenetic markers in developmental pathways and their potential link to diseases such as cancer and neurodegenerative disorders. We employed high-throughput sequencing technologies to analyze epigenetic modifications across various tissue types in both normal and diseased states. Our findings indicate significant differences in methylation and histone modification patterns between healthy and diseased tissues. Specifically, aberrant methylation was observed in genes associated with cell cycle regulation and apoptosis. The study concludes that these epigenetic changes could serve as biomarkers for early disease detection and targets for therapeutic intervention. Our research emphasizes the need for further studies to explore the potential of epigenetic therapies in personalized medicine.